Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Sierra Summit Advisors LLC

Sierra Summit Advisors LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 27,189 shares of the medical equipment provider’s stock after acquiring an additional 204 shares during the period. Intuitive Surgical makes up about 3.0% of Sierra Summit Advisors LLC’s holdings, making the stock its 5th largest position. Sierra Summit Advisors LLC’s holdings in Intuitive Surgical were worth $12,095,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Creekmur Asset Management LLC increased its holdings in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new stake in Intuitive Surgical during the second quarter worth $26,000. Able Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $28,000. Delos Wealth Advisors LLC lifted its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. Finally, LRI Investments LLC purchased a new position in Intuitive Surgical during the 1st quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Down 0.8 %

ISRG stock opened at $489.86 on Monday. Intuitive Surgical, Inc. has a twelve month low of $254.85 and a twelve month high of $496.18. The firm has a market capitalization of $173.75 billion, a PE ratio of 88.42, a PEG ratio of 5.41 and a beta of 1.39. The stock has a 50-day simple moving average of $463.74 and a two-hundred day simple moving average of $422.04.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the prior year, the firm posted $1.18 EPS. Intuitive Surgical’s revenue was up 14.5% on a year-over-year basis. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 238 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,629,115. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Robert Desantis sold 238 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total value of $113,645.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,629,115. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,555 shares of company stock valued at $24,267,737. 0.90% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. BTIG Research increased their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Barclays boosted their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Citigroup upped their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Truist Financial lifted their target price on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.